The Polaris International Equity Composite gained 12.40% (net of fees), outperforming the MSCI EAFE Index that returned 12.07 ...

London-listed AstraZeneca, known for its treatments for cancer, diabetes, and Covid-19, will invest $50 billion in U.S. facilities.

European shares fell on Tuesday, hit by mixed corporate earnings and anxiety over tariff negotiations between the U.S. and its trading partners, while the euro held steady. The Euro STOXX 600 index ...

The MSCI World Index returned 11.63%, while the Polaris Global Equity Composite gained 8.37% (net of fees). On a year-to-date ...